Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Preferred Stock Liabilities (2018 - 2021)

Historic Preferred Stock Liabilities for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q2 2021 value amounting to $1.9 million.

  • X4 Pharmaceuticals' Preferred Stock Liabilities changed N/A to $1.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $64.7 million for FY2018, which is N/A changed from last year.
  • Per X4 Pharmaceuticals' latest filing, its Preferred Stock Liabilities stood at $1.9 million for Q2 2021.
  • Over the past 5 years, X4 Pharmaceuticals' Preferred Stock Liabilities peaked at $64.7 million during Q3 2018, and registered a low of $1.9 million during Q1 2021.